Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Baitian Zhao
Observed names:
Bai-Tian Zhao,
Zhao, Bai-Tian
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0005-8858-6652
Observed ORCID:
0009-0005-8858-6652
OpenAlex ID:
A5091487928
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study
2024
·
Yan Gao
, Haixia He
, et al.
·
Signal Transduction and Targeted Therapy
·
51
Toripalimab plus anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm phase 2 trial (TORAL)
2024
·
Yuchen Zhang
, Qihua Zou
, et al.
·
Cell Reports Medicine
·
23
A multi-omic single-cell landscape reveals transcription and epigenetic regulatory features of t(8;21) AML
2025
·
Xue-Ping Li
, Yan Gao
, et al.
·
Journal of Translational Medicine
·
8
TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial
2025
·
Yuchen Zhang
, Qingsong Yin
, et al.
·
Med
·
5
Improved efficacy of concurrent anti-PD1 antibody plus AVD versus ABVD in patients with newly diagnosed early unfavorable and advanced stage classic Hodgkin lymphoma: a retrospective matched cohort study
2025
·
Mengqiu Wu
, Peng Sun
, et al.
·
Cancer Immunology Immunotherapy
·
5
PDF
Integration of CD34+CD117dim population signature improves the prognosis prediction of acute myeloid leukemia
2022
·
Xue-Ping Li
, Wei-Na Zhang
, et al.
·
Journal of Translational Medicine
·
5
PDF
Predictive factors and nomogram for the risk of cytokine release syndrome with anti-CD3 × CD20 bispecific antibodies for Chinese patients
2025
·
Peng Sun
, Cui Chen
, et al.
·
Cancer Immunology Immunotherapy
·
4
PDF
Integrative single-cell analysis of longitudinal t(8;21) AML reveals heterogeneous immune cell infiltration and prognostic signatures
2024
·
Xue-Ping Li
, Jiang-Tao Song
, et al.
·
Frontiers in Immunology
·
4
PDF
Radiation Therapy Improves Survival in Patients with Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Study
2024
·
Mengwen Wang
, Baitian Zhao
, et al.
·
Journal of Cancer
·
3
PDF
Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study
2023
·
Peng Sun
, Hang Yang
, et al.
·
Annals of Hematology
·
3
Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1
2023
·
Xue-Ping Li
, Yuting Dai
, et al.
·
International Immunopharmacology
·
3
First-in-human study of TQB3617, a BET inhibitor in patients with relapsed/refractory hematologic malignancies.
2024
·
Qingqing Cai
, Yi Xia
, et al.
·
Journal of Clinical Oncology
·
2
Outcomes of COVID ‐19 in patients with lymphomas participating in registered clinical trials: A real‐world study from China in the Omicron outbreak era
2023
·
Peng Sun
, Hang Yang
, et al.
·
Cancer Medicine
·
1
PDF
LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial
2026
·
Jun Cai
, Baitian Zhao
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
16
Citation count:
117
H-index:
5
I10-index:
2
Year
Topic
Type